Statistics for The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease

Total visits

views
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease 422

Total visits per month

views
January 2024 1
February 2024 3
March 2024 1
April 2024 7
May 2024 4
June 2024 0
July 2024 0

File Visits

views
Roberts_2019_Kawasaki.pdf 864

Top country views

views
United States 215
Germany 112
China 27
Sweden 7
Ukraine 7
United Kingdom 4
Turkey 3
Canada 2
France 2
South Korea 2
Russia 2
Singapore 2
Austria 1
Switzerland 1
India 1
Kazakhstan 1
Malaysia 1
Saudi Arabia 1

Top city views

views
Kiez 53
Wilmington 53
Gunzenhausen 51
Fairfield 24
Kansas City 18
Houston 14
Shenzhen 11
Ling 10
White Plains 9
Cambridge 8
Nürnberg 8
Kiev 7
Jacksonville 6
Stockholm 6
Washington 6
Ann Arbor 5
San Francisco 5
Beijing 2
Charlotte 2
Jackson 2
Ordu 2
Paris 2
Saint Louis 2
Sejong 2
Singapore 2
Toronto 2
Almaty 1
Bengaluru 1
Birmingham 1
Chicago 1
Clearwater 1
Commack 1
Detroit 1
Falls Church 1
Gilbert 1
Helena 1
Istanbul 1
Kista 1
Lake Mary 1
London 1
Matsuyama 1
Moscow 1
New York 1
Osaka 1
Riva 1
Riyadh 1
Saint Petersburg 1
Seattle 1
Seremban 1
Tustin 1
Vienna 1
Zürich 1